✦ LIBER ✦
Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors
✍ Scribed by Yun Jung Choi; Jin Kyung Rho; Byung-suk Jeon; Su Jin Choi; Su Cheol Park; Seung Sook Lee; Hye-Ryoun Kim; Cheol Hyeon Kim; Jae Cheol Lee
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 544 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.